Best tools for analysing stock dilution and share-based compensation
When a company grows, you want to know how much of that progress reaches each share you own. Employee awards, new share issuance and buybacks can change the answer. The useful comparison puts share-count changes and compensation costs beside the company's growth, then explains what caused them.
Start with Helmbeam for that recurring company check. In our stock-research app, the Shareholders lens and Numbers bring revenue per share, share-count trends and stock-based compensation together. Use the issuer's equity and EPS notes to explain the transactions behind the pattern. BamSEC helps with document search, TIKR with financial histories, and DilutionTracker with potential financing issuance.
Compare the tools by your ownership question
| Tool | Use it for | Detail to inspect |
|---|---|---|
| Helmbeam | Follow growth per share, share-count changes and stock-based compensation alongside the business | The available company history and the measure's period and share basis |
| EDGAR and a worksheet | Reconcile issued shares, awards, repurchases and EPS denominators | The actual equity, compensation and EPS notes |
| BamSEC | Find and compare ownership disclosures across filings | Which transaction each table describes |
| TIKR | Compare available financial and share histories | The exact share series and plan coverage |
| DilutionTracker | Investigate warrants, convertibles and potential financing issuance | Conversion terms and which scenarios are assumed |
| Carta-style cap-table software | Manage a private company's ownership record | Authorised access and the actual private securities |
Helmbeam: see whether growth reaches each share
Open the company's Snapshot and look at our Shareholders lens, then use Numbers to examine revenue per share, the share-count trend and stock-based compensation in dollars and as a share of revenue. This gives you a way to see whether rising company sales are translating into similar progress for each share, and how stock pay fits into that picture.
If revenue grows faster than revenue per share, inspect the share history and the issuer's explanation of issuance and repurchases. If compensation expense rises while the share count stays relatively flat, investigate the cash spent buying shares back and the award terms. These are different ownership questions, and the measures help you decide which one needs attention.
Full Numbers is available with Pro or your applicable free company slot. With Pro, keep the question in company Research and use agent research to investigate it, retaining saved brief versions for the next review. Our first-company walkthrough shows where to begin, and our methodology explains the Shareholders measures. Company coverage and available history determine which comparisons you can make.
Match each question to its evidence
| Question | Evidence to retrieve | Tool job |
|---|---|---|
| What expense was recognised? | Share-based compensation note and income statement | Filing search and source-linked extraction |
| What was granted or vested? | Award roll-forward and plan terms | Document search and a separate award worksheet |
| Did the outstanding share count grow? | Equity statement, issuance and repurchase disclosures | Comparable period history and reconciliation |
| What denominator was used for EPS? | Earnings-per-share note | Basic and diluted weighted-average data |
| What might happen next? | Unvested awards, options and future issuance terms | Explicit scenarios, not a single reported ratio |
Weighted-average shares measure a period; shares outstanding measure a point in time. Potential securities require their own treatment. The EPS framework distinguishes basic and diluted earnings per share, including the treatment of potential shares. IAS 33 overview.
Filings and BamSEC: best starting points for the reconciliation
The filing is where you find what the securities are, how they vest and which transactions changed the share count. Search the equity-compensation, stockholders' equity, EPS and repurchase sections. The EDGAR filing search is free; retain the document and report period for every input.
BamSEC describes document search, table tools, filing comparisons and links to particular passages. Those features are relevant when you repeat the exercise across periods or companies. Its published Pro price is $69 a month billed annually, so compare the annual commitment with how often you will use it. Feature and account access should be checked on the current plan page. BamSEC features, pricing.
The benefit is finding and organising evidence. You still need to decide whether a table reports grants, vesting, exercises or shares issued. Searching for the word “shares” does not resolve those differences.
Financial databases: best for the first trend check
TIKR provides financial history with depth that varies by plan. Use it to spot changes worth investigating, such as diluted weighted-average shares rising while a large buyback is being announced. Check that the dataset includes the exact share series and period you need, then return to the equity notes for the explanation. TIKR coverage.
A history chart should send you back to the notes when its pattern is surprising. Acquisitions, stock splits, option exercises and buybacks can all affect comparisons. A standardised field is a starting input, not a complete explanation of the ownership change.
Keep a separate worksheet for future scenarios. A database's historical diluted-share series does not necessarily capture all future grants or the terms under which outstanding awards might convert.
DilutionTracker: when the risk is potential financing issuance
DilutionTracker's explanation of its outstanding-share chart separates historical shares from potential issuance through warrants, convertible securities, at-the-market programmes and other facilities. That is a useful specialist view when financing terms are too important to reduce to the employee-compensation expense. DilutionTracker's chart definitions.
Read potential issuance as a scenario. The provider explicitly says the stacked potential sources do not all have to be used. A dollar financing capacity converted into shares using today's price will also change if the eventual issue price differs. Keep those estimates apart from both issued shares and the reported EPS denominator. For a new listing, our IPO research walkthrough shows how primary, secondary and potential shares enter separate parts of the model.
Why Carta-style cap tables belong in another category
Private-company cap-table systems manage ownership records, equity plans and financing scenarios for authorised participants. Carta's own explanation describes those ownership and access-controlled records. A public-market reader normally works from disclosed filings rather than an issuer's private cap table. Carta's cap-table guide.
If you are analysing employee equity in a private company, that category can be appropriate. If you own listed shares, a list headed “best dilution software” should not quietly replace public-company research tools with systems you cannot access and do not control.
Test a tool with one complete hypothetical example
Assume a company begins the year with 100 million shares. It grants 3 million awards, issues 2 million shares during the year and repurchases 1 million. With no other changes, the ending count is 101 million. The 3 million grants are not an extra 3 million current shares simply because they appear in the award note.
Suppose the income statement recognises $25 million of share-based compensation on $500 million of revenue. The expense is 5% of sales. That percentage describes an accounting cost relative to revenue; it is not a 5% increase in shares. Dividing the expense by today's share price would not reconstruct the issued-share roll-forward.
Now suppose net income rises from $200 million to $210 million, while diluted weighted-average shares rise from 100 million to 100.5 million. EPS rises from $2.00 to about $2.090, or 4.48%. Net income grew 5%, but each diluted weighted-average share received a smaller increase. The 100.5 million period-average denominator also differs from the 101 million ending count.
A useful tool lets you reproduce all three results without swapping definitions: 1% growth in ending shares, compensation expense equal to 5% of revenue and 4.48% growth in diluted EPS. If it supplies only one number, use it for that number and obtain the missing disclosures elsewhere.
Add cash and the buyback price
The hypothetical 1 million-share repurchase offsets part of the issuance, but it uses cash. At an assumed average repurchase price of $20, it costs $20 million. The ending share count still rises by 1 million because issuance exceeded repurchases. Keeping shares closer to flat has therefore required cash that is no longer available for investment, debt repayment or distributions.
Bring the cash cost back into your per-share research. If repurchases offset issuance, record how much cash that required and compare the resulting share count with revenue per share in Helmbeam. Our diluted-share checks explain the accounting comparison in more depth.
For recurring research, keep the same worksheet headings every quarter and retain the original filing links. That makes it possible to see whether improving company totals are reaching each share, and what cash was required along the way.
Frequently asked questions
What is the best free tool for analysing stock dilution?
Start with EDGAR or issuer filings and a spreadsheet. Retrieve the compensation, equity, EPS and repurchase notes, then reconcile their different quantities rather than relying on one dilution percentage.
Is share-based compensation expense the dilution rate?
No. Expense is an accounting amount. Grants, vesting, issued shares, outstanding shares and diluted weighted-average shares measure different things. The example shows why 5% of revenue in expense does not mean 5% more shares.
Does a buyback prove shareholders avoided dilution?
No. Compare issuance with repurchases and inspect the resulting share count. Also record the cash spent, because keeping shares flat can still require substantial funding.
Sources
7 referencesHelmbeam is a research and analysis tool operated by Scydex Ltd. Scydex Ltd is not authorised or regulated by the Financial Conduct Authority. Helmbeam does not provide investment advice, recommendations, or solicitations to buy or sell securities. All data is for informational purposes only. Past performance of any signal, cohort, or classification does not guarantee future results. All investing involves risk, including loss of principal. Always conduct your own research and consult a qualified financial adviser before making investment decisions.
Helmbeam is available as a free download on iOS and Android.